Collaboration Between the U.S. Biotech Industry and VCs to Accelerate Innovation

This session will discuss the latest trends in the U.S. biotech and life sciences sector and the ecosystem supporting startup growth.
While the U.S. market remains the global center, its changes have worldwide implications. We will delve into VC investment trends, cultural differences in fundraising, and the importance of a robust ecosystem with our panelists.Furthermore, we will cover the division of roles between major pharmaceutical companies and startups in the U.S., the pipeline from university research to commercialization, and mechanisms accelerating innovation.